血栓
光热治疗
材料科学
分子成像
溶栓
生物医学工程
溶栓药
纳米颗粒
纳米技术
医学
体内
癌症研究
内科学
生物
生物技术
心肌梗塞
作者
Leihao Lu,Qing Bao,Yi Miao,Qichao Cheng,Yuyin Chen,Shuxu Yang,Chuanbin Mao,Mingying Yang
标识
DOI:10.1002/adfm.202303331
摘要
Abstract Thrombotic disease poses a significant threat to human health as it blocks blood vessels and leads to severe symptoms. Effective treatment requires targeted therapy and precise localization of the thrombus, but traditional drugs are limited in their targeting ability and ability to locate the thrombus. To overcome these issues, a nanoparticle capable of both thrombus targeting and computed tomography (CT) imaging is developed. Phage display technology is used to screen for the thrombus‐targeting peptide termed GK, which is then linked to the surface of macroporous silica (Mp‐SiO 2 ) with a Bi core to create Mp‐Bi@SiO 2 ‐GK. The large pores of Mp‐Bi@SiO 2 ‐GK enable the transport of the drug Urokinase (UK), while the Bi core provides the capabilities of CT imaging and photothermal therapy. The Mp‐Bi@SiO 2 ‐GK nanoparticles precisely target thrombi in mouse carotid arteries and locate them via CT imaging. Furthermore, the combination of Bi‐enabled photothermal therapy and UK‐induced chemotherapy enhance the thrombolysis efficiency. Treatment with Mp‐Bi@SiO 2 ‐GK nanoparticles do not harm tissues/organs or affect liver/kidney metabolism. These results show that Mp‐Bi@SiO 2 ‐GK exhibits precise thrombus targeting and efficient imaging/treatment capability, making it a promising tool for the diagnosis and treatment of thrombosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI